Japan· JP-3999437G1022
セルトリズマブ ペゴル（遺伝子組換え）
A medicinal product containing セルトリズマブ ペゴル（遺伝子組換え）, registered in Japan by ユーシービージャパン, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- セルトリズマブ ペゴル（遺伝子組換え）
- Manufacturer
- ユーシービージャパン
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
セルトリズマブ ペゴル（遺伝子組換え） in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCIMZIAUCB Pharma SA, Brusel
- FinlandCimziaParanova Oy
- SpainCIMZIA 200 MG SOLUCION INYECTABLE EN CARTUCHO PARA DISPENSADOR DE DOSISUcb Pharma
- United KingdomCimzia 200mg/1ml solution for injection in a dose-dispenser cartridgeUCB Pharma Ltd
- SwedenCimzia 200 mg Injektionsvätska, lösning i förfylld injektionspennaUCB Pharma S.A.
- BelgiumCimzia 200 mgUCB Pharma
- IcelandCimziaUCB Pharma S.A.*
- United StatesCimziaUCB, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Cimzia
- Liechtenstein · Cimzia
- Norway · Cimzia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f8564ec7-c036-45da-bff9-237c770046aa GET /v1/drugs/f8564ec7-c036-45da-bff9-237c770046aa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "２００ｍｇ１ｍＬ１筒",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3999437G1022",
"category": "注射薬",
"price_yen": 52943,
"generic_name": "セルトリズマブ ペゴル（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "3999",
"transitional_expiry": null
}See everything about セルトリズマブ ペゴル（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.